An interventional study of Culinary Medicine Nutrition and Cooking Education in Chronic Kidney Disease, sponsored by University of Texas Southwestern Medical Center. Not yet recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-12.
Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center — 5 open to participants now, 6 under way, 1 of them phase 3. Renal Insufficiency, Chronic · University of Texas Southwestern Medical Center.
Among the 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center, this one is one of 2 that started in 2026, is one of 5 with no phase, and was the 11th registered.
3,098 studies on the registry are indexed under Renal Insufficiency, Chronic; 700 are open to participants now.
Browse Renal Insufficiency, Chronic studies →5 of the 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center are open now, in 1 country. Recruiting first, the newest first:
University of Texas Southwestern Medical Center · Sites in United States
Ages 18+ · Healthy volunteers
University of Texas Southwestern Medical Center · Sites in United States
Ages 18–65 · Healthy volunteers
University of Texas Southwestern Medical Center · Sites in United States
Ages 18+
University of Texas Southwestern Medical Center · Sites in United States
Ages 30–69
By country, each count listing its studies:
Of the 434 Renal Insufficiency, Chronic studies recruiting now, 245 (56%) set no upper age limit and 110 (25%) stop at 75 or younger; 43 take children under 18; 80 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 1
First in 2013; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 73 across 2,164 interventional studies indexed under Renal Insufficiency, Chronic.
Median enrollment 60 across the 8 interventional studies, 61 across the 3 observational. Of the 5 that completed or were terminated, 2 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Texas Southwestern Medical Center is the lead sponsor of 1,012 studies on the registry; 200 are open to participants now.
Of its 139 completed or terminated interventional studies of FDA-regulated products, 105 (76%) have results posted.
2 of the studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03565913Phase 3University of Texas Southwestern Medical CenterPotential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V | 2026-12-01 |
| NCT07368946University of Texas Southwestern Medical CenterPhosphate Assessment in Chronic Kidney Disease Patients Study | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Healthy eating plays an important role in kidney and heart health, and programs that use food as medicine can help improve diet and overall health, but the best ways to support healthy eating in community settings are not well understood. The purpose of this study is to compare two study groups to see which is more effective at improving kidney health and related health outcomes in adults with chronic kidney disease. One group receives fruits and vegetables with cooking education, and the other receives fruits and vegetables alone. The results may help researchers develop community-based programs to improve kidney and heart health, especially in populations at higher risk for kidney disease.
If the participant joins the study, the participant will complete a baseline visit, a 6-month visit, and a 12-month visit. Visits include questionnaires about the participant's health, diet, and cooking habits; a urine sample; a blood sample; blood pressure, height, weight, and waist measurements; and a brief, painless Veggie Meter® scan to measure fruit and vegetable intake. Participants will pick up weekly fruits and vegetables for 12 months. Those in the cooking group will also attend 12 weekly cooking and nutrition classes and receive follow-up newsletters and optional monthly virtual sessions. Depending on the group to which the participants are assigned, the total time commitment for the participants in this study will range from approximately 3 to 15 hours.
Participation is voluntary, involves minimal risk, and all information will be kept private. Possible risks include brief pain or bruising from the blood draw, mild discomfort from urine collection, minor risk of cuts or burns during cooking, and some questions may feel personal; the participant may skip any question. There may be no direct benefit to the participant, but the participant's participation may help improve nutrition and kidney health programs in the community.
Chronic kidney disease (CKD) impacts approximately 1/7 Americans, who experience asymptomatic progressive CKD leading to catastrophic complications, including kidney failure and death, and this R01 study will extend our previous R21 work to screen, identify , and intervene with culinary medicine philosophy within a community-based setting. The overall goals of the research study are to evaluate (1) urine albumin to creatinine ratio outcomes, (2) secondary endpoints including cardiovascular disease (CVD) measurements (i.e., systolic and diastolic blood pressure, body mass index, hemoglobin A1c, lipids), and (3) dietary adherence and change as well as nutrition knowledge and efficacy. This work will determine whether base-producing fruit and vegetables with or without culinary medicine improves CKD outcomes and associated CVD risk in lower socioeconomic community settings to inform future multi-site trials and population level implementation .
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group will receive a prescribed amount of free (at no charge) base-producing FV for 12 months through pick-up at one of two Brother Bills Helping Hand (BBHH) sites. BBHH clients pick up groceries weekly from either their main West Dallas campus or the South Dallas Community Market. This calculated FV amount averages 2-3 cups of base-producing FV daily. The FV Only group is considered standard care.
Participants will receive the same free base-producing as the FV Only group plus 12 weekly group nutrition and cooking education classes delivered through the UTSW Culinary Medicine program. Classes include hands-on cooking instruction, nutrition education, goal setting, behavioral strategies, and skill-building activities designed to improve healthy eating behaviors, self-efficacy, and motivation.
Behavioral: Culinary Medicine Nutrition and Cooking Education
A 12-week group-based culinary medicine program integrating nutrition education, cooking instruction, and behavior change strategies to support healthy eating and meal preparation.
Change from Baseline in Urine Albumin to Creatinine Ratio at 6 months
Diagnostic laboratory results for urinalysis will determine whether urine albumin-to-creatinine ratio (UACR) is reduced to a greater extent with the FV + Cook intervention as compared to FV Only at 6- months. High levels of urine albumin excretion predict increased risk for subsequent eGFR decline and its change during follow up is directly associated with risk for End-Stage Kidney Disease (ESKD).
Time frame: Baseline (enrollment), 6 months
Change in Urine Albumin to Creatinine Ratio at 12 months
Diagnostic laboratory results for urinalysis will determine whether urine albumin-to-creatinine ratio (UACR) is reduced to a greater extent with the FV + Cook intervention as compared to FV Only at 12-months. High levels of urine albumin excretion predict increased risk for subsequent eGFR decline and its change during follow up is directly associated with risk for ESKD.
Time frame: Baseline (enrollment), 12 months
Change from Baseline in Systolic and Diastolic Blood Pressure at 6 months
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) will be measured in millimeters of mercury (mmHg) using a validated instrument according to standardized guidelines. Two to three consecutive readings will be obtained and averaged for analysis. The outcome will be expressed as the mean change from baseline in SBP and DBP at the specified timepoint.
Time frame: Baseline (enrollment), 6 months
Change from Baseline in Systolic and Diastolic Blood Pressure at 12 Months
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) will be measured in millimeters of mercury (mmHg) using a validated instrument according to standardized guidelines. Two to three consecutive readings will be obtained and averaged for analysis. The outcome will be expressed as the mean change from baseline in SBP and DBP at the specified timepoint.
Time frame: Baseline (enrollment), 12 months
Change from Baseline in Glycated Hemoglobin (HbA1c) at 6 months
HbA1c will be measured as a percentage (%) from venous blood samples using a standardized laboratory method. The outcome will be expressed as the mean change from baseline in HbA1c at the specified timepoint.
Time frame: Baseline (enrollment), 6 Months
Change from Baseline in Glycated Hemoglobin (HbA1c) at 12 Months
HbA1c will be measured as a percentage (%) from venous blood samples using a standardized laboratory method. The outcome will be expressed as the mean change from baseline in HbA1c at the specified timepoint.
Time frame: Baseline (enrollment), 12 months
Change from Baseline in Body Mass Index (BMI) at 6 Months
Body mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m²). Body weight and height will be measured using standardized procedures, with weight measured using a calibrated scale and height using a stadiometer. The outcome will be expressed as the mean change from baseline in BMI at the specified timepoint.
Time frame: Baseline (enrollment), 6 Months
Change from Baseline in Body Mass Index (BMI) at 12 Months
Body mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m²). Body weight and height will be measured using standardized procedures, with weight measured using a calibrated scale and height using a stadiometer. The outcome will be expressed as the mean change from baseline in BMI at the specified timepoint.
Time frame: Baseline (enrollment), 12 months
Change in LDL Cholesterol (LDL-C) Level From Baseline to 6 months
LDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in LDL-C (mg/dL or mmol/L) from baseline to 6 months. A reduction in LDL-C from baseline indicates improvement.
Time frame: Baseline (enrollment), 6 Months
Change in LDL Cholesterol (LDL-C) Level From Baseline to 12 Months
LDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in LDL-C (mg/dL or mmol/L) from baseline to 12 months. A reduction in LDL-C from baseline indicates improvement.
Time frame: Baseline (enrollment), 12 months
Change in HDL Cholesterol (HDL-C) Level From Baseline to 6 months
HDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in HDL-C (mg/dL or mmol/L) from baseline to 6 months. An increase in HDL-C from baseline indicates improvement.
Time frame: Baseline (enrollment), 6 Months
Change in HDL Cholesterol (HDL-C) Level From Baseline to 12 Months
HDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in HDL-C (mg/dL or mmol/L) from baseline to 12 months. An increase in HDL-C from baseline indicates improvement.
Time frame: Baseline (enrollment), 12 months
Change in Lipoprotein(a) [Lp(a)] Level From Baseline to 6 months
Serum lipoprotein(a) concentration measured using a validated laboratory assay. The outcome is defined as the mean change in Lp(a) level (nmol/L or mg/dL) from baseline to 6 months. A reduction in Lp(a) concentration from baseline indicates improvement.
Time frame: Baseline (enrollment), 6 Months
Change in Lipoprotein(a) [Lp(a)] Level From Baseline to 12 Months
Serum lipoprotein(a) concentration measured using a validated laboratory assay. The outcome is defined as the mean change in Lp(a) level (nmol/L or mg/dL) from baseline to 6 months. A reduction in Lp(a) concentration from baseline indicates improvement.
Time frame: Baseline (enrollment), 12 months
Change in Dietary Intake [total energy intake (kcal/day)]
Mean daily energy intake calculated from dietary assessment data and expressed as kilocalories per day.
Time frame: Baseline (enrollment), 6 months
Change in Dietary Intake [total energy intake (kcal/day)]
Mean daily energy intake calculated from dietary assessment data and expressed as kilocalories per day.
Time frame: Baseline (enrollment), 12 months
Change in Dietary Intake [total fat intake (g/day)]
Mean daily total fat intake calculated from dietary assessment data and expressed as grams per day.
Time frame: Baseline (enrollment), 6 months
Change in Dietary Intake [total fat intake (g/day)]
Mean daily total fat intake calculated from dietary assessment data and expressed as grams per day.
Time frame: Baseline (enrollment), 12 months
Change in Dietary Intake [added sugar intake (g/day)]
Mean daily added sugar intake calculated from dietary assessment data and expressed as grams per day.
Time frame: Baseline (enrollment), 6 months
Change in Dietary Intake [added sugar intake (g/day)]
Mean daily added sugar intake calculated from dietary assessment data and expressed as grams per day.
Time frame: Baseline (enrollment), 12 months
Change in Dietary Intake [sodium intake (mg/day)]
Mean daily sodium intake calculated from dietary assessment data and expressed as milligrams per day.
Time frame: Baseline (enrollment), 6 months
Change in Dietary Intake [sodium intake (mg/day)]
Mean daily sodium intake calculated from dietary assessment data and expressed as milligrams per day.
Time frame: Baseline (enrollment), 12 months
Change in Dietary Intake [fruit and vegetable consumption (servings/day)]
Average daily servings of fruits and vegetables derived from dietary assessment data.
Time frame: Baseline (enrollment), 6 months
Change in Dietary Intake [fruit and vegetable consumption (servings/day)]
Average daily servings of fruits and vegetables derived from dietary assessment data.
Time frame: Baseline (enrollment), 12 months
Change in Dietary Intake [selected macro- and micronutrient intake]
Mean daily intake of selected nutrients, including carbohydrates, protein, fiber, vitamins, and minerals, calculated from dietary assessment data and expressed in standard units (g/day, mg/day, or µg/day, as appropriate).
Time frame: Baseline (enrollment), 6 months
Change in Dietary Intake [selected macro- and micronutrient intake]
Mean daily intake of selected nutrients, including carbohydrates, protein, fiber, vitamins, and minerals, calculated from dietary assessment data and expressed in standard units (g/day, mg/day, or µg/day, as appropriate).
Time frame: Baseline (enrollment), 12 months
Change in Dietary quality
Diet quality will be calculated from ASA24 dietary recall data using the Diet Quality Index-International (DQI-I). Both the total (summative) DQI-I score and mean DQI-I score will be analyzed, with higher scores indicating better overall diet quality.
Time frame: Baseline (enrollment), 6 months
Change in Dietary quality
Diet quality will be calculated from ASA24 dietary recall data using the Diet Quality Index-International (DQI-I). Both the total (summative) DQI-I score and mean DQI-I score will be analyzed, with higher scores indicating better overall diet quality.
Time frame: Baseline (enrollment), 12 months
Change in skin carotenoid status
Skin carotenoid status measured by noninvasive spectroscopy. Higher scores indicate greater carotenoid status and are associated with higher fruit and vegetable intake and better overall diet quality.
Time frame: Baseline (enrollment), 6 months
Change in skin carotenoid status
Skin carotenoid status measured by noninvasive spectroscopy. Higher scores indicate greater carotenoid status and are associated with higher fruit and vegetable intake and better overall diet quality.
Time frame: Baseline (enrollment), 12 months
Plan to share: No — IPD sharing will not be shared with other researchers. Only aggregated, de-identified data will be shared if needed.
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Oct 2031, 60 months later.
Of 580 non-industry interventional studies with no phase under Renal Insufficiency, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 45. This study's planned 60 months is above that.
Counting every sponsor, half of 620 studies reached it within 23 months; a quarter within 10 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Renal Insufficiency, Chronic →
University of Texas Southwestern Medical Center →